Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Bulimia Nervosa

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Bulimia Nervosa in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Bulimia Nervosa: An eating disorder that is characterized by a cycle of binge eating (BULIMIA or bingeing) followed by inappropriate acts (purging) to avert weight gain. Purging methods often include self-induced VOMITING, use of LAXATIVES or DIURETICS, excessive exercise, and FASTING.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butt, I1
Hong, A1
Di, J1
Aracena, S1
Banerjee, P1
Shen, CH1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Bulimia Nervosa

ArticleYear
The effects of serotonin1A receptor on female mice body weight and food intake are associated with the differential expression of hypothalamic neuropeptides and the GABAA receptor.
    Neuropeptides, 2014, Volume: 48, Issue:5

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anorexia Nervosa; Body Weight; Bulimia Nervosa; Fee

2014